Personalized mRNA cancer vaccine shows promise in extending life span in melanoma trial

from ABC7 RSS Feed · host ABCNews

Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among high-risk patients with melanoma.

Episode metadata supplied by the publisher feed · Published Aug 19, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Personalized mRNA cancer vaccine shows promise in extending life span in melanoma trial

0:00 0:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

When was this ABC7 RSS Feed episode published?

This episode was published on August 19, 2026.

Can I download this ABC7 RSS Feed episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!